ADAP Advocacy Launches New Commercial Urging Reforms to 340B Drug Pricing Program
ADAP Advocacy launches new commercial advocating for reforms to the 340B Drug Pricing Program. CEO Macsata emphasizes the importance of accountability and transparency in federal programs. Learn more about the campaign and its implications.
This news highlights the importance of accountability and transparency in federal drug programs, drawing attention to potential parallels with past financial crises. It underscores the need for oversight to address issues like declining charity in hospitals and rising healthcare executive compensation.
